Will YODA End Debate Over rhBMP-2?

Independent review finds BMP no better than graft for lumbar spinal fusion

Terry Stanton

The word is in from the Yale Open Data Access (YODA) project: recombinant human bone morphogenetic protein (rhBMP-2), the product marketed as Infuse® by Medtronic, Inc., offers no appreciable benefit over autograft in spinal fusion surgery. The judgment is the result of an unprecedented move by the manufacturer, which turned over all patient data to the YODA project for review.

To View Full Article You Must